Please login to the form below
US Centers for Disease Control and Prevention
This page shows the latest US Centers for Disease Control and Prevention news and features for those working in and with pharma, biotech and healthcare.
FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
The US Food and Drug Administration (FDA) and US Centers for Disease Control and Prevention (CDC) are investigating whether Pfizer/BioNTech’s updated COVID-19 vaccine could be linked with an ... Neither Pfizer and BioNTech nor the CDC or FDA have
Latest news
-
WHO reports new Omicron subvariant cases detected in 29 countries worldwide
December. Data from the US Centers for Disease Control and Prevention (CDC) has estimated that XBB and XBB.1.5 accounted for 44.1% of US COVID-19 cases in the ... change in public health strategies is warranted, is currently evaluating the rapidly
-
Kinarus’ KIN001 shows strong antiviral activity against BA.2 and BA.5 Omicron subvariants
The BA.5 subvariant currently accounts for about one-quarter of COVID-19 cases in the US,” said Professor Ulrich Schubert from the Institute of Clinical and Molecular Virology at the ... closely tracked by the US Centers for Disease Control and
-
FDA approves Scynexis’ Brexafemme for recurrent vulvovaginal candidiasis
The US Food and Drug Administration (FDA) has approved a second indication for Scynexis’ Brexafemme (ibrexafungerp tablets) for the reduction in the incidence of recurrent vulvovaginal candidiasis (RVVC). ... US Centers for Disease Control and
-
CDC shows new BQ.1 and BQ 1.1 Omicron subvariants account for 44% of US COVID-19 cases
The two new variants accounted for over 32% of US cases the prior week. ... Data from the US Centers for Disease Control and Prevention (CDC) has estimated that the two new Omicron subvariants, BQ.1 and BQ.1.1, accounted for over 44% of US
-
GSK to submit drug application for new antibiotic to US FDA
The company expects to submit regulatory filings to the US Food and Drug Administration in the first half of 2023 for gepotidacin which, if approved, could become the first drug in ... Antibiotic-resistant E coli has been identified by both the US
More from news
Approximately 3 fully matching, plus 68 partially matching documents found.
Latest Intelligence
-
How behavioural design is transforming the role and impact of life sciences in healthcare
These seamlessly connect patients and doctors, enabling prevention and real-time disease management in a more cost-effective way. ... II] Up to 40% of annual deaths from each of five leading US causes are preventable, Centers for Disease Control and
-
Advancing women in healthcare
She has had a long and distinguished career serving patients, training first as an infectious disease doctor, and then expanding her horizons continually to become one of the world’s most ... Centers for Disease Control and Prevention (CDC) and
-
The threat of antimicrobial resistance
the low commercial value placed on antibiotic drugs compared to more lucrative sectors such as cardiovascular disease and cancer. ... By January 2018, the US Centers for Disease Control and Prevention had reported 29 cases of MCR resistance identified
-
Deal Watch June 2016
US Centers for Disease Control and Prevention (CDC)). ... The five year contract with BARDA will cover activities related to phase 3 clinical studies for the Intercept RBC System in the US and associated manufacturing and regulatory activities to
-
Communicating in a crisis
For example about 600, 000 people die of heart disease in the US each year, according to the Centers for Disease Control and Prevention, yet Ebola has taken the headlines. ... people are fully educated on the disease and treatment and prevention
More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.
Latest appointments
-
Merck names head of strategic communications
Merck has a unique role and a responsibility to contribute and I welcome this opportunity to lead teams of experts who will help us achieve our mission of saving lives and ... Prior to this role, she served as director of the US Centers for Disease
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- Roche’s Polivy recommended by NICE for lymphoma therapy
- Sanofi/Regeneron’s Dupixent approved by EC for eosinophilic oesophagitis
- ASH 2022: bad blood but big advances
- AbbVie’s Rinvoq approved by MHRA for Crohn's disease
- Eli Lilly announces $450m investment in US manufacturing site
- AstraZeneca’s Imfinzi plus chemotherapy approved by MHRA for biliary tract cancer
- ICR calls for improved biomarker cancer tests to help personalise treatment
- EIT Health marks World Cancer Day with €6m pledge for new healthcare delivery models
- World Cancer Day: encouraging men to put their health first
- World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
- Strategic behaviour
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- Creabilis names Catherine Moukheibir as chairman of the board
- World Health Organization releases latest set of COVID-19 guidelines
- AZ’s COVID-19 vaccine trial to continue after Brazilian volunteer death
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
PMHub
Collected Group
Collected Group is a forward thinking healthcare communication company that supports biopharma and diagnostic companies to engage in more lasting...
Latest intelligence
- World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
- Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
- Strategic behaviour
- Strong strategising depends on your colleagues’ behaviour...
- Pharmaceutical Marketing Strategies For The Digital Age
- In the digital age, a strong digital marketing strategy is crucial for businesses, especially in the highly competitive and complex pharmaceutical industry. There are key trends shaping pharmaceutical marketing, such...
